Advertisement

Advertisement
Dilon Technologies forms alliance with Terason Ultrasound in diagnostic imaging Print E-mail
User Rating: / 0
PoorBest 


Medical Articles - Cancer (Oncology)
Wednesday, 19 November 2008

Devices/Technology

Dilon Technologies, Inc., the leader in molecular breast imaging, announced today that they have formed an alliance with Terason Ultrasound to offer an extended imaging ability when molecular breast imaging and ultrasound may be essential.

BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers, specially for women with high risk factors or that present with questionable mammograms. With BSGI, metabolic activity is assessed and cancerous cells typically display as "hot spots."

Terason is the innovator and world leader in integrating patented microsystem technology with an Apple MacBook Pro PC. The Terason t3000(TM) Ultrasound System offers premium imaging performance with the portability and functionality of a notebook. When used as a complement to the Dilon 6800 Gamma Camera, physicians are able to move from BSGI to ultrasound without leaving the exam room.

Bob Moussa, President and CEO of Dilon Technologies said, "We are proud to partner with Terason to complement BSGI with ultrasound when appropriate. Through innovative products and partnerships like this, Dilon continues to enlarge its offerings to be the best in patient care and cancer detection."

The Terason t3000 offers best-in-class image quality; easiness of use with a dual user interface; and an integrated info management and communications protocol in one system. For rapid on-the-spot, accurate scanning in a wide array of clinical applications, transducers speedily connect to the system allowing technicians to perform an ultrasound exam at the point of patient care. Terason's patented high-density, beam-forming architecture provides a superior performance cost-effective ultrasound solution.

The ultrasound system is built upon an industry respected combination of the Apple PC coupled with Windows Operating System to provide seamless networking capabilities, compatibility with different applications, standard connections, and software updates. The system includes DICOM, Wireless, Integrated CD/DVD, and USB ability. The ergonomically designed slide out dual-user interface is highly simple to use. The Terason t3000(TM) Ultrasound System is a powerful ultrasound designed to work smarter, enhance workflow, and promote efficiency and diagnostic confidence.

"BSGI has proven to be an valuable adjunct to mammography and ultrasound in the diagnosis of breast cancer. We are excited to be in a partnership with Dilon as we both continue to offer valuable advances in care," said Alice Chiang, Ph.D., Terason's CEO.

http://www.dilon.com/

 
Latest news in this category:

Scientists find new way to 'track' response to cancer drugs
Tuesday, 06 January 2009
Medical Research News Scientists have found a new way of accurately measuring the success of experimental cancer drugs, according to a study published in Cancer Research.

Cancer cells pull off 'Houdini' escape to evade chemotherapy
Tuesday, 06 January 2009
Medical Research News Scientists have revealed for the first time that cancer cells can reverse a process which irrevocably commits normal cells to die, in a study published in the British Journal of Cancer.

A novel glioblastoma mouse model developed
Tuesday, 06 January 2009
Medical Research News Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma-the most regular and deadly brain cancer in humans-that nearly resembles the development and progression of human brain tumors that arise naturally.

Inherited factors play key role in breast cancer
Tuesday, 06 January 2009
Women's Health News New research in mice and five independent collections of human breast tumors has enabled National Cancer Institute (NCI) scientists to affirm that genes for factors contributing to susceptibility for breast cancer metastasis can be inherited.

Scientists now able to differentiate between normal stem cells and cancer stem cells in humans
Tuesday, 06 January 2009
Medical Research News One of the present handicaps of cancer treatments is the problem of aiming these treatments at destroying malignant cells without killing healthful cells in the process.

Obesity may contribute to the development of ovarian cancer
Tuesday, 06 January 2009
Women's Health News A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.

Metadherin gene linked to metastasis of breast cancer
Tuesday, 06 January 2009
Women's Health News A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually...
Latest News
Advertisement
Popular articles

Black women get breast cancer two decades earlier than white women
Thursday, 17 January 2008
Black British women in Hackney, East London, are diagnosed with breast cancer 21 years younger than white British women, according to a Cancer Research UK study published online in the British Journal of Cancer.

Post-Op Chemo Fails to Boost Survival in Stomach Cancers
Wednesday, 12 March 2008
TUESDAY, March 11 Chemotherapy following surgery does not enhance survival in stomach cancer patients, says an Italian study. Currently, surgery is the only treatment that can potentially cure non-metastatic gastric cancer, according to background info in the study.

Specialized Care for Ovarian Cancer Improves Outcomes
Wednesday, 12 March 2008
TUESDAY, March 11 Treatment at semi-specialized or specialized hospitals advanced survival time for ovarian cancer patients, a Dutch study found. For the study, the researchers examined data on 8,621 ovarian cancer patients treated in the Netherlands between 1996 and 2003.

Genetic Markers May Predict Lung Cancer Recurrence
Thursday, 13 March 2008
WEDNESDAY, March 12 Certain genetic alterations in tumors and tissue from patients with early-stage lung cancer may identify those at greatest risk for cancer recurrence, say researchers at the Johns Hopkins Kimmel Cancer Center.

New behavioral risk factors for head and neck cancers
Wednesday, 12 March 2008
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out 2 different sets of risk factors for head and neck cancers, suggesting that there are 2 entirely different kinds of the disease.

New surgery technique for pancreatic cancer offers hope to sufferers
Tuesday, 11 March 2008
Just days after it was announced in the media that Hollywood actor Patrick Swayze was being treated for pancreatic cancer, doctors in Britain have performed a new operation for people with the enhanced stage of the disease.

A road map to safer pain control, cost savings during colonoscopies
Wednesday, 12 March 2008
Advertisement
© 2009 Health and Medical Articles